All medical devices sold in Uganda must be registered with the National Drug Authority (NDA) before they can be supplied. For orthopaedic implant distributors and hospital procurement teams, understanding the registration process is essential for maintaining compliant inventories.
The three registration tracks
The NDA operates three registration tracks based on prior regulatory approval. Track 1 applies to products already registered in IMDRF member countries (Australia, Canada, EU, Japan, US) and receives expedited review. Track 2 covers WHO-prequalified products or those registered in Stringent Regulatory Authority countries. Track 3 is the standard review pathway for products with no prior approval by reference agencies.
Required documentation
Applications require a cover letter, manufacturer's authorisation letter, CE marking certificate or equivalent, ISO 13485 certificate, free sale certificate from the country of origin, technical file including biocompatibility and performance data, and product labelling samples. All documents must be in English with certified translations where applicable.
Classification system
Medical devices are classified into four risk classes: Class A (lowest risk, e.g., surgical instruments), Class B (low-moderate risk, e.g., orthopaedic plates), Class C (moderate-high risk, e.g., implantable devices), and Class D (highest risk). Orthopaedic implants typically fall into Class C, requiring more comprehensive documentation.
Timeline and validity
NDA registration typically takes 6 to 12 months. Once registered, licences are valid for five years. Post-market surveillance and adverse event reporting are ongoing requirements for all registered products.